Skip to main content

Hyperlipidemia (Primary Prevention) - Lifestyle Changes and/or Lipid Lowering Therapy

CBE ID
0611
Endorsement Status
1.1 New or Maintenance
Previous Endorsement Cycle
Is Under Review
No
1.3 Measure Description

Percentage of patients aged 20 years and older with risk factors for coronary artery disease who have an elevated LDL-C and who are taking a lipid lowering agent or have initiated therapeutic lifestyle changes

        • 1.14 Numerator

          Patients who are taking lipid lowering therapy or who have initiated therapeutic lifestyle changes.

        • 1.15 Denominator

          Patients aged 20 and older with risk factors for coronary artery disease who had an elevated LDL-C in the past 12 months.

        • Exclusions

          SPECIFIC EXCLUSIONS:
          • Presence of TSH Labs Result Value > 10 In the past 6 Months
          • Presence of NEPHROTIC SYNDROME in past 12 months
          • CAD Validation is confirmed
          • Diabetes Validation is confirmed
          • PAD Validation is confirmed
          • AAA in the past
          • Carotid endarterectomy in the past

          GENERAL EXCLUSIONS:
          • Evidence of metastatic disease or active treatment of malignancy (chemotherapy or radiation therapy) in the last 6 months;
          • Patients who have been in a skilled nursing facility in the last 3 months
          • Patient or provider feedback indicating allergy, intolerance or contraindication to the drug in the past

        • Most Recent Endorsement Activity
          Measure Retired and Endorsement Removed National Voluntary Consensus Standards For Clinically Enriched Administrative Data
          Initial Endorsement
          Last Updated
          Removal Date
        • Steward
          ActiveHealth Management
          Steward Organization POC Email